Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Bajo

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 16, 2008
[Is the automated peritoneal dialysis technique better than ambulatory continuous peritoneal dialysis for patients starting on peritoneal dialysis?]J Portolés, M A Bajo
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1997
Kt/V is a better indicator of adequacy than weekly creatinine clearance in CAPDR Selgas, M A Bajo
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 16, 2008
[Do biocompatible solutions better protect residual renal function than conventional solutions used in peritoneal dialysis?]G Del Peso, M A Bajo
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 4, 2007
[Evidence-based peritoneal dialysis. Prescription and management of complications]G del Peso, M A Bajo, R Selgas
Biochemical and Biophysical Research Communications|March 3, 1975
N-acetylphenylalanyl-tRNA specific hydrolase in yeastM A Bajo, M C Moratilla, C F Heredia
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 26, 2010
[Role played by peritoneal dialysis in treating refractory heart failure]J D Montejo, M A Bajo, G del Peso, et al.
Revista Clinica Espanola|August 1, 1995
[Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus]A Vigil, P Gallar, A Oliet, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 16, 1998
Successful treatment of peritonitis in CAPD with intraperitoneal rifampinA Paiva, A Cirugeda, M A Bajo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 1999
Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patientsJ J Díez, P Iglesias, A Aguilera, et al.
Clinical Endocrinology|December 7, 2000
Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysisJ J Díez, P Iglesias, R Selgas, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 16, 2008
[Is the automated peritoneal dialysis technique better than ambulatory continuous peritoneal dialysis for patients starting on peritoneal dialysis?]J Portolés, M A Bajo
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1997
Kt/V is a better indicator of adequacy than weekly creatinine clearance in CAPDR Selgas, M A Bajo
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 16, 2008
[Do biocompatible solutions better protect residual renal function than conventional solutions used in peritoneal dialysis?]G Del Peso, M A Bajo
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 4, 2007
[Evidence-based peritoneal dialysis. Prescription and management of complications]G del Peso, M A Bajo, R Selgas
Biochemical and Biophysical Research Communications|March 3, 1975
N-acetylphenylalanyl-tRNA specific hydrolase in yeastM A Bajo, M C Moratilla, C F Heredia
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|January 26, 2010
[Role played by peritoneal dialysis in treating refractory heart failure]J D Montejo, M A Bajo, G del Peso, et al.
Revista Clinica Espanola|August 1, 1995
[Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus]A Vigil, P Gallar, A Oliet, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 16, 1998
Successful treatment of peritonitis in CAPD with intraperitoneal rifampinA Paiva, A Cirugeda, M A Bajo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 1999
Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patientsJ J Díez, P Iglesias, A Aguilera, et al.
Clinical Endocrinology|December 7, 2000
Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysisJ J Díez, P Iglesias, R Selgas, et al.
Pageof 9